ANALYSIS OF ENTEROSORBENTS REPRESENTED ON THE RETAIL PHARMACEUTICAL MARKET

DOI: https://doi.org/None
Issue: 
6
Year: 
2017

G.A. Galkina, PhD; E.I. Gribkova, PhD; M.M. Kurashov, PhD; E.M. Rasner People’s Friendship University of Russia; 6, Miklukho-Maklai St., Moscow 117198, Russian Federation

Introduction. Endogenous intoxication is a syndrome that is characteristic of many pathological processes and conditions. Enterosorbents are used to timely eliminate toxins from the body. Objective: to carry out a comparative marketing analysis of drugs from the group of enterosorbents represented on the retail pharmaceutical market. Material and methods. The objects of the investigation were 12 drugs from the group of enterosorbents represented in the drugstores of Moscow. Content analysis, a sociological survey using a questionnaire, and SWOT (strength, weakness, opportunities, and threats) analysis were applied in the investigation. Results. The criteria that were used to comparatively analyze enterosorbents were as follows: assignment to medicines or biologically active additives, a drug classification group, composition, indications, contraindications, clinically proven efficacy, ease of use, and calculation of costs. The gross profit brought by the enterosorbents sold in the pharmacies was estimated. A matrix was built, which allowed identification of competitive niches of enterosorbents. A sociological survey of the buyers of Enterosgel was made; methods for its promotion on the pharmaceutical market were devised. Conclusion. Mechanisms for promoting the sales of enterosorbents are outlined. The inclusion of highly effective enterosorbents in the pharmaceutical brand portfolio will take into account the interests of buyers and contribute to the improvement of the quality of pharmaceutical care.

Keywords: 
enterosorbents
comparative analysis
enterosgel
SWOT (strength
weakness
opportunities
and threats) analysis

References: 
  1. Shhekina M.I., Panchuk M.S. Aspekty primeneniya e`nterosorbentov pri intoksikacii razlichnogo geneza v ambulatornoy praktike. Medicinskiy sovet, 2013; 3: 67–70.
  2. Maev I.V., Samsonov A.A., Golubev N.N. Aspekty klinicheskogo primeneniya e`nterosorbenta «Neosmektin». RMZh, 2008; 2: 62.
  3. Belyaeva O., Shevchenko Yu., Semenov V. Ispol`zovanie preparata «E`nterosgel`» dlya lecheniya i profilaktiki infekciy i intoksikaciy. Kievskaya medicinskaya akademiya poslediplomnogo obrazovaniya. [E`lektronnyy resurs]. Rezhim dostupa:http://www.provisor.com.ua/archive/2002/N10/art_23.php
  4. Nagornaya N.V., Dubovaya A.V. Detoksikacionnye svoystva i klinicheskaya e`ffektivnost` e`nterosorbenta «E`nterosgel`» v kompleksnom lechenii razlichnyh zabolevaniy u detey. Doneckiy nacional`nyy medicinskiy universitet im. M. Gor`kogo. [E`lektronnyy resurs]. Rezhim dostupa://http://www.mif-ua.com/archive/article/12948
  5. Pokazateli sorbcii (iz dokumentov proizvoditeley).
  6. Galkina G.A., Rasner E.M., Akinina Yu.A., Zayceva K.N. Razrabotka priemov prodvizheniya lekarstvennyh preparatov gruppy e`nterosorbentov na osnove sravnitel`nogo analiza. Sbornik materialov «Sovremennye problemy farmacevticheskoy bezopasnosti: racional`noe primenenie lekarstvennyh sredstv (s ispol`zovaniem e`nterosorbentov) i professional`naya kvalifikaciya specialistov», 2015.